Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: A systematic reviewCapsule Summary
Background: Systemic glucocorticoids are first-line treatment options for autoimmune blistering diseases; however, their long-term use is associated with significant toxicities. Objective: To evaluate the side effects of steroid-sparing agents and compare them with those of steroids. Methods: We sea...
Saved in:
Main Authors: | Faith A.P. Zeng (Author), Anna Wilson, MD, BMedRadSc (Author), Tabrez Sheriff, MD (Author), Dedee F. Murrell, MA, BMBCh, MD, FACD, DSc (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report
by: Aslı Bilgic-Temel, MD, et al.
Published: (2019) -
Pemphigoid gestationis and intravenous immunoglobulin therapy
by: Anes Yang, MD, BMed, MPH, et al.
Published: (2018) -
New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature
by: Rachel R. Xuan, et al.
Published: (2018) -
Teledermatology in the COVID-19 pandemic: A systematic reviewCapsule Summary
by: Chee Hoou Loh, BMed, MD, MRCP, et al.
Published: (2021) -
Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort studyCapsule Summary
by: Yicong Liang, MD, et al.
Published: (2022)